Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Reid Weyant Merryman, M.D.

Concepts (86)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease13202313773.700 Why?
Hematopoietic Stem Cell Transplantation18202455502.240 Why?
Lymphoma, Mantle-Cell320232391.460 Why?
Lymphoma, Follicular220244501.360 Why?
Transplantation, Autologous13202421091.290 Why?
Lymphoma, Large B-Cell, Diffuse9202413951.210 Why?
Lymphoma, Non-Hodgkin3202013730.880 Why?
Immunotherapy, Adoptive7202414170.840 Why?
Neoplasm Recurrence, Local12202392070.790 Why?
Neurotoxicity Syndromes120232940.670 Why?
Salvage Therapy4202112650.620 Why?
Immune Evasion120193570.540 Why?
Lymphoma3202318870.520 Why?
Antineoplastic Combined Chemotherapy Protocols102024115860.500 Why?
Stem Cell Transplantation5202316000.430 Why?
Asparaginase120122250.370 Why?
Neoplasm, Residual320239940.330 Why?
Drug Resistance, Neoplasm2202151630.330 Why?
Antineoplastic Agents32023135530.300 Why?
Leukocytes, Mononuclear2202318200.260 Why?
Transplantation Conditioning4202115550.260 Why?
Combined Modality Therapy3202485380.240 Why?
Schools, Medical120118740.230 Why?
Antigens, CD19220234120.220 Why?
Transplantation, Homologous3202146370.220 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1201215170.220 Why?
Antibodies, Monoclonal5202391010.210 Why?
Positron-Emission Tomography2202264130.210 Why?
Lymphoma, T-Cell, Peripheral120231240.200 Why?
Humans3520247523410.180 Why?
Disease-Free Survival6202367810.180 Why?
Immunotherapy3202446010.170 Why?
Education, Medical1201117130.160 Why?
Prognosis42024293270.160 Why?
Retrospective Studies122024791270.160 Why?
Health Policy1201126560.160 Why?
Cytarabine120206960.150 Why?
Antibodies, Bispecific120201850.150 Why?
Proto-Oncogene Proteins c-bcl-6120161890.130 Why?
Central Nervous System1202313310.130 Why?
Immunoconjugates120228650.120 Why?
Graft vs Host Disease2201729630.120 Why?
Receptors, Antigen, T-Cell1202325150.120 Why?
Survival Rate42022127460.120 Why?
Clinical Trials as Topic2202079950.110 Why?
Disease Management1202424790.110 Why?
Switzerland220233160.100 Why?
T-Lymphocytes32023100360.100 Why?
Adult1120242169130.090 Why?
Statistics, Nonparametric1201728420.090 Why?
Proto-Oncogene Proteins c-myc120169900.090 Why?
Tumor Microenvironment1202337550.090 Why?
Young Adult42024576290.090 Why?
Proto-Oncogene Proteins c-bcl-21201613910.090 Why?
Neoplasm Staging12024110640.080 Why?
Molecular Targeted Therapy1202027820.080 Why?
Congresses as Topic220237950.080 Why?
Treatment Outcome42024642450.080 Why?
CD8-Positive T-Lymphocytes1202144950.080 Why?
Neoplasms12017218080.080 Why?
Kaplan-Meier Estimate1201765010.070 Why?
Aged920241665620.070 Why?
Neoplasm Proteins1201835990.070 Why?
Methotrexate1201217020.060 Why?
Remission Induction2202423670.060 Why?
Hematologic Neoplasms1201718640.060 Why?
Female1020243860530.060 Why?
Middle Aged820242170190.050 Why?
Adolescent52024867650.050 Why?
Data Collection1201133020.050 Why?
Male820243548810.040 Why?
Follow-Up Studies12021390790.040 Why?
Recurrence2202284200.040 Why?
Cohort Studies12020409840.040 Why?
Canada1202021030.030 Why?
Fluorodeoxyglucose F181202219930.030 Why?
Infant12012356730.020 Why?
Child, Preschool12012416590.020 Why?
Prospective Studies22020538070.020 Why?
Aged, 80 and over22022583000.020 Why?
Survival Analysis12017101770.010 Why?
Gene Expression1201775800.010 Why?
Child12012789980.010 Why?
United States12011714420.010 Why?
Practice Guidelines as Topic1201873990.010 Why?
Quality of Life12020131530.010 Why?
Merryman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (86)
Explore
_
Co-Authors (40)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.